17β-Hydroxysteroid dehydrogenase-3 deficiency: From pregnancy to adolescence

Journal of Endocrinological Investigation

Volumn 32, Issue 8, 2009, Pages 666-670

  Bertelloni, S ^a   Balsamo, A ^b   Giordani, L ^c   Fischetto, R ^d   Russo, G ^e   Delvecchio, M ^c   Gennari, M ^b   Nicoletti, A ^b   Maggio, M C ^f   Concolino, D ^g   Cavallo, L ^c   Cicognani, A ^b   Chiumello, G ^e   Hiort, O ^h   Baroncelli, G I ^a   Faienza, M F ^c  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF BARI   (Italy)

^d Paediatric Hospital Giovanni XXIII Polyclinic of Bari   (Italy)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF PALERMO   (Italy)

^g UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^h UNIVERSITY OF LÜBECK   (Germany)

Author keywords

17 hydroxysteroid dehydrogenase type 3 gene; 17 hydroxysterotd dehydrogenase type 3 deficiency; Disorders of sex development; Male female sex reversal; Testotesterone 4 androstenedione ratio

Indexed keywords

17BETA HYDROXYSTEROID DEHYDROGENASE 3; ANDROSTENEDIONE; GONADORELIN DERIVATIVE; TESTOSTERONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; 17BETA HYDROXYSTEROID DEHYDROGENASE TYPE 3; 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3; HYDROXYSTEROID DEHYDROGENASE;

17BETA HYDROXYSTEROID DEHYDROGENASE 3 DEFICIENCY; ADOLESCENCE; ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLITORIS; ENZYME DEFICIENCY; FEMALE; FETUS; FOLLOW UP; GENDER IDENTITY DISORDER; GENE MUTATION; GENETIC SCREENING; GONADECTOMY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INFANT; INGUINAL HERNIA; ITALY; KARYOTYPE 46,XY; LABORATORY TEST; PHENOTYPE; PREGNANCY; PRENATAL DIAGNOSIS; PRESCHOOL CHILD; PUBERTY DISORDERS; SCHOOL CHILD; TESTIS; VIRILIZATION; GENETICS; MALE; PUBERTY; SEX DIFFERENTIATION DISORDER;

17-HYDROXYSTEROID DEHYDROGENASES; FEMALE; HUMANS; MALE; PREGNANCY; PRENATAL DIAGNOSIS; PUBERTY; SEX DIFFERENTIATION DISORDERS;

EID: 72449125117     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03345738     Document Type: Article

References (31)

1. Hughes IA, Houk C, Ahmed SF, Lee PA; LWPES Consensus Group; ESPE Consensus Group. Consensus statement on management of intersex disorders. Arch Dis Child 2006, 91: 554-563 (Pubitemid 44023350)
2. Faienza MF, Giordani L, Delvecchio M, Cavallo L. Clinical, endocrine, and molecular findings in 17beta-hydroxysteroid dehydrogenase type 3 deficiency. J Endocrinol Invest 2008, 31: 85-91.
3. Bertelloni S, Dati E, Hiort O. Diagnosis of 17β-hydroxysteroid dehydrogenase deficiency: a review. Expert Review Endocrinol Metab 2009, 4: 53-65.
4. Geissler WM, Davis DL, Wu L, et al. Male pseudohermaphroditism caused by mutations of testicular 17beta-hydroxysteroid dehydrogenase 3. Nat Genet 1994, 7: 34-39 (Pubitemid 24977991)
5. Andersson S, Geissler WM, Wu L, et al. Molecular genetics and pathophysiology of 17beta-hydroxysteroid dehydrogenase 3 deficiency. J Clin Endocrinol Metab 1996, 81: 130-136 (Pubitemid 26035013)
6. Mendonca BB, Inacio M, Arnhold IJ, et al. Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 2000, 79: 299-309.
7. Lee YS, Kirk JM, Stanhope RG, et al. Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls. Clin Endocrinol (Oxf) 2007, 67: 20-28
8. Sinnecker GH, Hiort O, Dibbelt L, et al. Phenotypic classification of male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Am J Med Genet 1996, 63: 223-230 (Pubitemid 26147447)
9. Cacciari E, Milani S, Balsamo A, et al. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 2006, 29: 581-593 (Pubitemid 44446267)
10. Sane K, Pescovitz OH. The clitoral index: a determination of clitoral size in normal girls and in girls with abnormal sexual development. J Pediat 1992, 120: 264-266
11. Boehmer ALM, Brinkmann AO, Sandkuijl LA, et al. 17beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics and worldwide distribution of ancient and de novo mutations. J Clin Endocrinol Metab 1999, 84: 4713-4721
12. Twesten W, Holterhus P, Sippell WG, et al. Clinical, endocrine, and molecular genetic findings in patients with 17beta-hydroxysteroid dehydrogenase deficiency. Horm Res 2000, 53: 26-31. (Pubitemid 30759311)
13. Crofton PM, Evans AE, Groome NP, Taylor MR, Holland CV, Kelnar CJ. Inhibin B in boys from birth to adulthood: relationship with age, pubertal stage, FSH and testosterone. Clin Endocrinol (Oxf) 2002, 56: 215-221 (Pubitemid 34233959)
14. Moghrabi N, Hughes IA, Dunaif A, Andersson S. Deleterious missense mutations and silent polymorphism in the human 17β-hydroxysteroid dehydrogenase 3 gene (HSD17β3). J Clin Endocrinol Metab 1998, 83: 2855-2860
15. Cassorla FG, Golden SM, Johnsonbaugh RE, Heroman WM, Loriaux DL, Sherins RJ. Testicular volume during early infancy. J Pediatr 1981, 99: 742-743
16. Taranger J, Engström I, Lichtenstein H, Svennberg-Redegren I. VI. Somatic pubertal development. Acta Paediatr Scand Suppl 1976, 258: 121-135
17. Parisi MA, Ramsdell LA, Burns MW, et al. A Gender Assessment Team: experience with 250 patients over a period of 25 years. Genet Med 2007, 9: 348-357
18. Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab 2008, 22: 119-134 (Pubitemid 351218281)
19. Rosier A. Steroid 17[beta]-hydroxysteroid dehydrogenase deficiency in man: An inherited form of male pseudohermaphroditism. J Steroid Biochem Mol Biol 1992, 43: 989-1002.
20. Balducci R, Toscano V, Wright F, et al. Familial male pseudohermaphroditism with gynaecomastia due to 17beta-hydroxysteroid dehydrogenase deficiency. A report of 3 cases. Clin Endocrinol (Oxf) 1985, 23: 439-444
21. Latronico AC, Arnhold IJ. Inactivating mutations of LH and FSH receptors - from genotype to phenotype. Pediatr Endocrinol Rev 2006, 4: 28-31.
22. Yalinkaya A, Yayla M, Erdemoglu M. Prenatal diagnosis of a fetus with androgen insensitivity syndrome (AIS). Prenat Diagn 2007, 27: 856-857 (Pubitemid 47425406)
23. Andersson AM. Inhibin B in the assessment of seminiferous tubular function. Baillieres Best Pract Res Clin Endocrinol Metab 2000, 14: 389-397 (Pubitemid 32000305)
24. Bilbao JR, Loridan L, Audi L, Gonzalo E, Castaño L. A novel missense (R80W) mutation in 17β-hydroxysteroid dehydrogenase type 3 gene associated with male pseudohermaphroditism. Eur J Endocrinol 1998, 139: 330-333 (Pubitemid 28430547)
25. Rashid HH, Cos LR, Weinberg E, Messing EM. Testicular microlithiasis: a review and its association with testicular cancer. Urol Oncol 2004, 22: 285-289 (Pubitemid 38993305)
26. Cools M, Drop SL, Wolffenbuttel KP, Oosterhuis JW, Looijenga LH. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Endocr Rev 2006, 27: 468-484
27. Mains LM, Vakili B, Lacassie Y, Andersson S, Lindqvist A, Rock JA. 17β-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite. Fertil Steril 2008, 89: 228.e13-17
28. Margiotti K, Kim E, Pearce CL, Spera E, Novelli G, Reichardt JK. Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men. Prostate 2002, 53: 65-68
29. Cohen-Kettenis PT. Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 2005, 34: 399-410.
30. Hiort O, Reinecke S, Thyen U, et al. Puberty in disorders of somatosexual differentiation. J Pediatr Endocrinol Metab 2003, 16: 297-306.
31. Cohen-Kettenis PT, Delemarre-van De Waal HA, Gooren U. The Treatment of Adolescent Transsexuals: Changing Insights. J Sex Med 2008, 5: 1892-1897